XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -2.49%54.75B | -3.35%14.24B | -8.48%13.04B | 10.27%13.62B | -6.50%13.85B | -28.48%56.14B | -20.63%14.73B | -32.18%14.25B | -41.63%12.35B | -16.61%14.81B |
Operating revenue | -2.49%54.75B | -3.35%14.24B | -8.48%13.04B | 10.27%13.62B | -6.50%13.85B | -28.48%56.14B | -20.63%14.73B | -32.18%14.25B | -41.63%12.35B | -16.61%14.81B |
Cost of revenue | 1.12%38.36B | 1.15%10.05B | -2.44%9.4B | 9.92%9.36B | -3.03%9.56B | -21.75%37.94B | -21.28%9.93B | -25.45%9.63B | -33.42%8.51B | -2.91%9.86B |
Gross profit | -10.00%16.38B | -12.66%4.19B | -21.10%3.64B | 11.07%4.26B | -13.41%4.29B | -39.35%18.2B | -19.26%4.8B | -42.94%4.62B | -54.17%3.84B | -34.90%4.95B |
Operating expense | 13.31%3.6B | 72.70%1.22B | -8.16%732M | 0.25%802M | -3.21%845M | -30.19%3.18B | -38.09%707M | -26.20%797M | -36.46%800M | -18.41%873M |
Selling and administrative expenses | 64.26%1.16B | 266.28%630M | 10.06%186M | -20.00%164M | 11.95%178M | 13.16%705M | -10.42%172M | 14.19%169M | 113.54%205M | -14.97%159M |
Other taxes | 0.63%2.09B | 15.56%520M | -11.19%476M | 4.69%536M | -3.65%555M | -38.35%2.07B | -34.50%450M | -36.42%536M | -49.80%512M | -29.24%576M |
Other operating expenses | -10.80%355M | -16.47%71M | -23.91%70M | 22.89%102M | -18.84%112M | -29.43%398M | -67.68%85M | 3.37%92M | -41.96%83M | 100.00%138M |
Operating profit | -14.93%12.78B | -27.42%2.97B | -23.80%2.91B | 13.92%3.46B | -15.59%3.44B | -40.99%15.03B | -14.78%4.09B | -45.51%3.82B | -57.30%3.04B | -37.60%4.08B |
Net non-operating interest income expense | -70.20%-1.11B | -342.11%-276M | -2.67%-269M | -12.55%-278M | -11.33%-285M | 24.30%-651M | 323.53%114M | -1.16%-262M | 9.19%-247M | 7.91%-256M |
Non-operating interest income | ---- | ---- | ---- | ---- | ---- | 111.28%412M | ---- | ---- | ---- | ---- |
Non-operating interest expense | 4.23%1.11B | -7.38%276M | 2.67%269M | 12.55%278M | 11.33%285M | 0.76%1.06B | 21.14%298M | 1.16%262M | -9.19%247M | -7.91%256M |
Other net income (expense) | 4.39%2B | 350.00%279M | 9.41%593M | -16.67%475M | -12.04%650M | -47.24%1.91B | -87.32%62M | -21.22%542M | -29.63%570M | -54.91%739M |
Gain on sale of security | 154.35%50M | 113.68%13M | 150.91%28M | -164.29%-9M | -59.09%18M | -126.21%-92M | -144.81%-95M | -159.14%-55M | -80.00%14M | 283.33%44M |
Earnings from equity interest | -0.87%1.71B | 4.51%440M | 13.66%441M | -2.18%403M | -15.63%421M | -17.35%1.72B | -26.14%421M | -30.84%388M | -21.37%412M | 17.14%499M |
Special income (charges) | -113.55%-29M | -411.54%-81M | -102.06%-2M | -3,800.00%-39M | 1.09%93M | -80.35%214M | -53.57%26M | 330.95%97M | -100.38%-1M | -88.71%92M |
-Less:Impairment of capital assets | 471.43%80M | --46M | ---- | --34M | --0 | 216.67%14M | ---- | ---- | --0 | -50.00%1M |
-Write off | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --11M | ---- | ---- |
-Gain on sale of property,plant,equipment | -77.63%51M | -225.00%-35M | -101.85%-2M | -400.00%-5M | 0.00%93M | -78.83%228M | -26.32%28M | 370.00%108M | -100.38%-1M | -88.62%93M |
Other non- operating income (expenses) | 281.69%271M | 67.93%-93M | 12.50%126M | -17.24%120M | 13.46%118M | -32.38%71M | 16.91%-290M | 47.37%112M | 429.55%145M | -75.36%104M |
Income before tax | -16.06%13.67B | -30.35%2.97B | -21.10%3.24B | 8.83%3.66B | -16.53%3.81B | -42.30%16.29B | -18.55%4.26B | -44.89%4.1B | -56.08%3.36B | -42.24%4.56B |
Income tax | -16.96%4.43B | -47.18%664M | -9.68%1.18B | 17.70%1.33B | -23.45%1.26B | -44.17%5.33B | -36.71%1.26B | -55.30%1.3B | -54.98%1.13B | -23.24%1.64B |
Net income | -15.62%9.25B | -23.31%2.31B | -26.41%2.06B | 4.35%2.33B | -12.64%2.55B | -41.34%10.96B | -7.45%3.01B | -38.19%2.8B | -56.62%2.23B | -49.30%2.92B |
Net income continuous Operations | -15.62%9.25B | -23.31%2.31B | -26.41%2.06B | 4.35%2.33B | -12.64%2.55B | -41.34%10.96B | -7.45%3.01B | -38.19%2.8B | -56.62%2.23B | -49.30%2.92B |
Minority interest income | ||||||||||
Net income attributable to the parent company | -15.62%9.25B | -23.31%2.31B | -26.41%2.06B | 4.35%2.33B | -12.64%2.55B | -41.34%10.96B | -7.45%3.01B | -38.19%2.8B | -56.62%2.23B | -49.30%2.92B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | -12.50%7M | -18.18%9M | -41.67%35M | -52.94%8M | 11M | |||||
Net income attributable to common stockholders | -15.35%9.25B | -22.41%2.31B | -26.41%2.06B | 4.41%2.32B | -12.62%2.54B | -41.34%10.92B | -6.80%2.97B | -38.19%2.8B | -56.63%2.22B | -49.49%2.91B |
Basic earnings per share | -13.88%7.82 | -24.90%1.9 | -24.03%1.77 | 8.15%1.99 | -9.24%2.16 | -37.89%9.08 | -3.07%2.53 | -34.55%2.33 | -53.77%1.84 | -46.03%2.38 |
Diluted earnings per share | -13.80%7.81 | -24.60%1.9 | -24.14%1.76 | 7.61%1.98 | -9.66%2.15 | -37.82%9.06 | -3.45%2.52 | -34.65%2.32 | -53.54%1.84 | -45.79%2.38 |
Dividend per share | -20.20%3.12 | 34.48%0.78 | -29.73%0.78 | -29.73%0.78 | -29.73%0.78 | 8.91%3.91 | -52.07%0.58 | 141.30%1.11 | -4.31%1.11 | 46.05%1.11 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |